Compare SOHU & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOHU | CLPT |
|---|---|---|
| Founded | 1996 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 467.9M |
| IPO Year | 2018 | 2009 |
| Metric | SOHU | CLPT |
|---|---|---|
| Price | $12.60 | $9.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $19.50 | ★ $23.50 |
| AVG Volume (30 Days) | 31.2K | ★ 649.3K |
| Earning Date | 11-16-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | N/A | $32.54 |
| Revenue Next Year | $2.46 | $15.41 |
| P/E Ratio | $1.16 | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $11.61 | $8.27 |
| 52 Week High | $17.30 | $27.27 |
| Indicator | SOHU | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 45.49 | 31.63 |
| Support Level | $12.41 | $8.61 |
| Resistance Level | $13.71 | $15.30 |
| Average True Range (ATR) | 0.31 | 0.48 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 58.06 | 5.20 |
Sohu.com Ltd provides online media, games, and search products and services on PCs and mobile devices in China. The company operates in Sohu and Changyou segments. Sohu is an online media content and services provider. Through its social features, Sohu also enables users to generate and distribute content, as well as interact with each other on a platform. Changyou is an online game developer and operator. It generates maximum revenue from the Changyou segment.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.